High-grade and hormone-treated prostate cancer express high levels of thymidylate synthase-Reference-Cited by-同舟云学术

High-grade and hormone-treated prostate cancer express high levels of thymidylate synthase

Published:2006-07 Issue:1 Volume:98 Page:197-200
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

INOUE TAKAHIRO,SEGAWA TAKEHIKO,SHIRAISHI TAIZO,YAMADA TOMOMI,KINUKAWA NAOKO,YOSHIDA TORU,TODA YOSHINOBU,SHIMIZU YOSUKE,NAKAMURA EIJIRO,KINOSHITA HIDEFUMI,KAMOTO TOSHIYUKI,OGAWA OSAMU

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2006.06219.x/fullpdf

Reference22 articles.

1. 5-Fluorouracil: mechanisms of action and clinical strategies

2. Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody

3. Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer;Oncotarget;2015-02-25

2. Possibility of using mRNA expression levels for nucleic acid-metabolizing enzymes within prostate cancer cells as indices for prognostic factors;Oncology Letters;2010-09-01

3. The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma;Oncology Reports;2009-07-23

4. Thymidylate synthase was associated with patient prognosis and the response to adjuvant therapy in bladder cancer;BJU International;2009-02